An interventional study of Technology Enriched Rehabilitation in Stroke and Rehabilitation, sponsored by University of Strathclyde. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-22.
Sponsored by University of Strathclyde · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The Biomedical Engineering Dept, University of Strathclyde, co-creates rehabilitation technology. In 2023-2024 a clinical study (NCT06787768) was conducted to understand the feasibility of a multi-technology approach to rehabilitation early after stroke. This was successful and leads to the next phase which is to gather preliminary evidence of the effectiveness of this approach by monitoring change in the mobility of patients who receive this intervention compared with usual care which will be gathered through a data linkage project (tracking the outcomes from matched patients from other parts of Scotland who receive usual care).
Rationale A well-established multi-disciplinary research group at the University of Strathclyde (UoS) Biomedical Engineering department have developed and tested a multi-technology rehabilitation model as a solution to the gap between clinical need and current provision. The technology enriched rehabilitation model has been tested under controlled conditions with chronic stroke survivors (at least one-year post stroke) and shown to be feasible with preliminary evidence of efficacy. The model has since been tested on acute/sub-acute stroke patients in an NHS stroke unit and found to be feasible and clinically acceptable with early evidence of an increased rehabilitation dose. This early stroke population has greater potential for recovery as the brain is more receptive to recovery through structural changes to neural pathways (neuroplasticity), therefore delivering higher intensity rehabilitation is therefore more critical at this phase of rehabilitation.
Funding has now been secured to progress this work by gathering evidence on the effectiveness of this approach in recovery mobility (walking, balance and) as well as gathering preliminary evidence of cost effectiveness (healthcare use).
Overall aim To determine whether early, technology-based rehabilitation after stroke improves mobility compared with usual care, using a virtual control group from national linked data, and to identify factors that influence recovery and assess economic benefit.
Specific questions;
Outcome measures The primary variable for comparison will be the modified Rivermead Mobility Index (mRMI) which is a standard measure of mobility routinely used in the NHS, including NHS Lanarkshire. In addition to this the research team will carry out the following tests before the intervention and before discharge.
Measures of motor recovery:
10mwt, five times sit to stand, short version of the BERG Balance Scale, Timed up and Go test, Action Research Arm Test
Health economic measures:
Length of initial stay, Hospital readmissions, stroke recurrence, mortality, Prescription use, GP visits, Level of paid social care STUDY DESIGN and METHODS of DATA COLLECTION AND DATA ANALYIS This is a phase 2, Pre-post design with a non-equivalent virtual control group (VCG) from data linkage study in line with Medical Research Council recommendations for development of a complex intervention.
Duration spent on activities within the 'technology enriched rehabilitation space' will be timed by the NHS staff supporting the participants within the room, and these will be collated by the research assistant.
Additional outcome measures In order to further inform future studies the research team will collate the scores of the standard care
Sample size Sample size / detectable difference. For a between-group difference of 1.6 points on the 15-point Rivermead Mobility Index (SD 3.0) (GAPS Study, Glasgow Augmented Physiotherapy Study (GAPS) group, 2004) with α = 0.05 and 80% power, the study requires ≈56 participants per group. Allowing for 10% attrition, the recruitment target of 62 participants per group is considered sufficient. The previous feasibility study recruited 60 participants over 9 months, a similar target is therefore regarded as achievable. A larger sample size for the virtual group (matched on diagnosis, age and Heath Board area) is planned (n=150) to improve statistical power. This would give a total sample of 212.
Data Analysis Analysis will be completed by the research team at the University of Strathclyde.
This pilot efficacy study will test the superiority of technology enriched rehabilitation over usual care by comparing the primary outcome measure (mRMI).
Exploratory analysis of other outcome measures of balance, upper limb function and walking recorded from the sample at UHW will be used to understand change in the primary variable (mRMI).
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
This study's planned enrollment of 62 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Browse Stroke studies →University of Strathclyde is the lead sponsor of 20 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The intervention is a rehabilitation programme delivered entirely through technology, including virtual reality (immersed and non-immersed), treadmills, weight suspension and movement resistance, and power assistance equipment located in a gym-like space located on an acute stroke unit. Individual programs are designed and reviewed by a physiotherapist using principles of intensity, feedback, cognitive engagement, and aerobic activity to address the goals identified by the participant and scores from outcome measures at baseline. Supervision is provided by rehabilitation assistants Participants attend according to their tolerance (assessed by clinical team) up to 2 hours per day until discharged home.
Other: Technology Enriched Rehabilitation
The intervention is a rehabilitation programme delivered entirely through technology, including virtual reality (immersed and non-immersed), treadmills, weight suspension and movement resistance, and power assistance equipment located in a gym-like space on an acute stroke unit (NHS Lanarkshire). Individual programs are designed and reviewed by a physiotherapist using principles of intensity, feedback, cognitive engagement, and aerobic activity to address the goals identified by the participant and scores from outcome measures at baseline. Attendance at the gym is supervised and assisted by rehabilitation support workers. Participants can attend daily for 2 hours maximum until discharge, according to their tolerance and judgement of the clinical ward team.
Modified Rivermead Mobility Index (MRMI)
The Modified Rivermead Mobility Index (MRMI) is a standardized 8-item assessment that evaluates mobility tasks including turning over, balance, transfers, walking, and stair climbing. Scores range from 0 to 40, with higher scores indicating greater mobility. The items include: Turning over Lying to sitting Sitting balance Sitting to standing Standing Transfers Walking indoors Stairs
Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.
10-Metre Walk Test (10MWT)
A standardized assessment of gait speed over a 10-metre distance. Faster times indicate better walking ability.
Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.
Five Times Sit-to-Stand Test (FTSTST)
A functional lower-limb strength and mobility test measuring the time required to stand up from a seated position five times. Shorter times indicate better performance.
Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.
Berg Balance Scale (BBS)
A 14-item scale assessing static and dynamic balance. Scores range from 0 to 56, with higher scores indicating better balance.
Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.
Action Research Arm Test (ARAT)
A standardized 19-item measure of upper-limb function assessing grasp, grip, pinch, and gross arm movement. Scores range from 0 to 57; higher scores indicate better arm function.
Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.
Grip Strength
Maximum isometric grip force measured using a dynamometer. Higher values indicate greater strength.
Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.
Therapy Outcome Measure (TOM)
A multidimensional clinical scale capturing impairment, activity, participation, and well-being
Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.
Fatigue Assessment Scale (FAS)
A 10-item questionnaire evaluating physical and mental fatigue. Scores range from 10 to 50, with higher scores indicating more severe fatigue.
Time frame: Baseline (between consent and start of intervention) and immediately before hospital discharge.
Length of Initial Hospital Stay
Total number of days from hospital admission to discharge.
Time frame: Through completion of the initial hospital stay.
Hospital Readmissions
Number of unplanned readmissions to any hospital setting.
Time frame: Through study completion and up to 12 months post hospital discharge.
Stroke Recurrence
Number of clinically confirmed recurrent strokes.
Time frame: Through study completion and up to 12 months post hospital discharge.
Prescription Use
Number and type of prescribed medications captured from medical records.
Time frame: Through study completion and up to 12 months post hospital discharge.
Ongoing Rehabilitation Use
Use (number of sessions) of outpatient or community-based rehabilitation services following discharge.
Time frame: Through study completion and up to 12 months post hospital discharge.
GP Visits
Number of visits to primary care providers during the follow-up period.
Time frame: Through study completion and up to 12 months post hospital discharge.
Level of Paid Social Care
Amount and type of paid social care support used by participants (e.g., home care hours).
Time frame: Through study completion and up to 12 months post hospital discharge
No study locations are listed for this record.
Plan to share: Yes — Data will be posted on the University's Data Sharing repository (PURE)
Supporting information: Study protocol, Clinical study report
Time frame: July 2027 Until July 2032
Access criteria: This will be publicly available
Data sharing details ↗ · www.strath.ac.uk
Start is estimated for Apr 2026; primary completion for Jun 2027, 14 months later.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 14 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Strathclyde